Repay Holdings Corp
F:0YR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Repay Holdings Corp
F:0YR
|
US |
|
A
|
Abbott Laboratories
XBER:ABL
|
US |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
M
|
Medtronic PLC
XMUN:2M6
|
IE |
|
AxoGen Inc
F:LT3
|
US |
|
Frontdoor Inc
NASDAQ:FTDR
|
US |
|
M
|
MSA Safety Inc
F:M07
|
US |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
|
Banco de Sabadell SA
OTC:BNDSF
|
ES |
|
L
|
Lindsay Corp
SWB:LMF
|
US |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
Wall St Price Targets
0YR Price Targets Summary
Repay Holdings Corp
According to Wall Street analysts, the average 1-year price target for 0YR is 7.07 EUR with a low forecast of 4.34 EUR and a high forecast of 10.63 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0YR's stock price target?
Price Target
7.07
EUR
According to Wall Street analysts, the average 1-year price target for 0YR is 7.07 EUR with a low forecast of 4.34 EUR and a high forecast of 10.63 EUR.
What is the Revenue forecast for Repay Holdings Corp?
Projected CAGR
31%
The compound annual growth rate for Revenue over the next 3 years is 31%.
What is the Gross Profit forecast for Repay Holdings Corp?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 3 years is 24%.
